Amphotericin B in children with malignant disease: a comparison of the toxicities and pharmacokinetics of amphotericin B administered in dextrose versus lipid emulsion.
about
Flaws in design, analysis and interpretation of Pfizer's antifungal trials of voriconazole and uncritical subsequent quotationsPopulation pharmacokinetics of amphotericin B in children with malignant diseasesFungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents.Incidence, Predictors, and Impact on Hospital Mortality of Amphotericin B Nephrotoxicity Defined Using Newer Acute Kidney Injury Diagnostic CriteriaAntifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective.
P2860
Amphotericin B in children with malignant disease: a comparison of the toxicities and pharmacokinetics of amphotericin B administered in dextrose versus lipid emulsion.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Amphotericin B in children wit ...... extrose versus lipid emulsion.
@en
Amphotericin B in children wit ...... extrose versus lipid emulsion.
@nl
type
label
Amphotericin B in children wit ...... extrose versus lipid emulsion.
@en
Amphotericin B in children wit ...... extrose versus lipid emulsion.
@nl
prefLabel
Amphotericin B in children wit ...... extrose versus lipid emulsion.
@en
Amphotericin B in children wit ...... extrose versus lipid emulsion.
@nl
P2093
P2860
P1476
Amphotericin B in children wit ...... extrose versus lipid emulsion.
@en
P2093
P2860
P304
P407
P577
1999-06-01T00:00:00Z